Logo image of BTCW.CA

BITCOIN WELL INC (BTCW.CA) Stock Fundamental Analysis

TSX-V:BTCW - TSX Venture Exchange - CA09173W1014 - Common Stock - Currency: CAD

0.125  -0.02 (-13.79%)

Fundamental Rating

1

BTCW gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. BTCW may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, BTCW is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BTCW has reported negative net income.
BTCW had a positive operating cash flow in the past year.
BTCW.CA Yearly Net Income VS EBIT VS OCF VS FCFBTCW.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA -76.45%
ROE N/A
ROIC N/A
ROA(3y)-60.37%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BTCW.CA Yearly ROA, ROE, ROICBTCW.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 100 -100 200 -200 300

1.3 Margins

BTCW's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for BTCW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.24%
GM growth 5YN/A
BTCW.CA Yearly Profit, Operating, Gross MarginsBTCW.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

BTCW does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BTCW has been increased compared to 1 year ago.
BTCW has a worse debt/assets ratio than last year.
BTCW.CA Yearly Shares OutstandingBTCW.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 50M 100M 150M 200M
BTCW.CA Yearly Total Debt VS Total AssetsBTCW.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

BTCW has an Altman-Z score of 1.28. This is a bad value and indicates that BTCW is not financially healthy and even has some risk of bankruptcy.
BTCW has a debt to FCF ratio of 47.71. This is a negative value and a sign of low solvency as BTCW would need 47.71 years to pay back of all of its debts.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 47.71
Altman-Z 1.28
ROIC/WACCN/A
WACC6.71%
BTCW.CA Yearly LT Debt VS Equity VS FCFBTCW.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

BTCW has a Current Ratio of 1.16. This is a normal value and indicates that BTCW is financially healthy and should not expect problems in meeting its short term obligations.
BTCW has a Quick Ratio of 1.10. This is a normal value and indicates that BTCW is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.1
BTCW.CA Yearly Current Assets VS Current LiabilitesBTCW.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

BTCW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.54%.
BTCW shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.07%.
The Revenue has been growing slightly by 1.62% on average over the past years.
EPS 1Y (TTM)-33.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.44%
Revenue 1Y (TTM)25.07%
Revenue growth 3Y1.62%
Revenue growth 5YN/A
Sales Q2Q%56.65%

3.2 Future

The Earnings Per Share is expected to grow by 18.56% on average over the next years. This is quite good.
The Revenue is expected to grow by 219.38% on average over the next years. This is a very strong growth
EPS Next Y-33.33%
EPS Next 2Y0%
EPS Next 3Y18.56%
EPS Next 5YN/A
Revenue Next Year1576.86%
Revenue Next 2Y385.36%
Revenue Next 3Y219.39%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BTCW.CA Yearly Revenue VS EstimatesBTCW.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
BTCW.CA Yearly EPS VS EstimatesBTCW.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.01 -0.02 -0.03 -0.04

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BTCW. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BTCW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BTCW.CA Price Earnings VS Forward Price EarningsBTCW.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF 47.84
EV/EBITDA N/A
BTCW.CA Per share dataBTCW.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

A more expensive valuation may be justified as BTCW's earnings are expected to grow with 18.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0%
EPS Next 3Y18.56%

More info and screens

0

5. Dividend

5.1 Amount

BTCW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BITCOIN WELL INC

TSX-V:BTCW (3/7/2025, 7:00:00 PM)

0.125

-0.02 (-13.79%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners26.47%
Ins Owner ChangeN/A
Market Cap27.52M
Analysts84
Price Target0.29 (132%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.99%
Min Revenue beat(2)3.81%
Max Revenue beat(2)28.17%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-17.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)20%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF 47.84
P/OCF 47.84
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)0
FCFY2.09%
OCF(TTM)0
OCFY2.09%
SpS0.34
BVpS-0.05
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -76.45%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.19%
FCFM 0.78%
ROA(3y)-60.37%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.24%
GM growth 5YN/A
F-Score3
Asset Turnover4.3
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 47.71
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.1
Altman-Z 1.28
F-Score3
WACC6.71%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.44%
EPS Next Y-33.33%
EPS Next 2Y0%
EPS Next 3Y18.56%
EPS Next 5YN/A
Revenue 1Y (TTM)25.07%
Revenue growth 3Y1.62%
Revenue growth 5YN/A
Sales Q2Q%56.65%
Revenue Next Year1576.86%
Revenue Next 2Y385.36%
Revenue Next 3Y219.39%
Revenue Next 5YN/A
EBIT growth 1Y-79.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year115.02%
EBIT Next 3Y48.88%
EBIT Next 5YN/A
FCF growth 1Y94.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.9%
OCF growth 3YN/A
OCF growth 5YN/A